论文部分内容阅读
成都地奥集团是1988年8月18日借款50万元创办的局新技术企业,经过20多个春秋的不懈努力,己成为集天然药物、合成药物、基因工程药物、微生物药物、药物制剂研制为一体的大型骨干制药企业,是国内实力最强的药物研制、中试、生产基地之一,是世界上最大的高纯度留体皂苷和高纯度胸腺肽生产企业,矿业能源领域极具发展潜力的生力军。
Chengdu Austrian Group was established on August 18, 1988 Borrow 50000 yuan Bureau of new technology enterprises, after more than 20 years of unremitting efforts, has become a natural medicine, synthetic drugs, genetic engineering drugs, microbiological drugs, pharmaceutical preparations As one of the major backbone pharmaceutical companies, is the strongest domestic drug development, pilot, one of the production base, is the world’s largest high-purity residual saponin and high purity thymosin production enterprises, mining energy has great potential for development new force.